Evangelisti C - Search Results

1

Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside.

Marvi MV, Neri I, Evangelisti C, Ramazzotti G, Asioli S, Zoli M, Mazzatenta D, Neri N, Morandi L, Tonon C, Lodi R, Franceschi E, McCubrey JA, Suh PG, Manzoli L, Ratti S. Marvi MV, et al. Among authors: evangelisti c. Biomolecules. 2023 May 7;13(5):798. doi: 10.3390/biom13050798. Biomolecules. 2023. PMID: 37238668 Free PMC article. Review.

2

Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.

Tabellini G, Tazzari PL, Bortul R, Evangelisti C, Billi AM, Grafone T, Martinelli G, Baccarani M, Martelli AM. Tabellini G, et al. Among authors: evangelisti c. Br J Haematol. 2005 Sep;130(5):716-25. doi: 10.1111/j.1365-2141.2005.05679.x. Br J Haematol. 2005. PMID: 16115127 Free article.

3

Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?

Martelli AM, Faenza I, Billi AM, Manzoli L, Evangelisti C, Falà F, Cocco L. Martelli AM, et al. Among authors: evangelisti c. Cell Signal. 2006 Aug;18(8):1101-7. doi: 10.1016/j.cellsig.2006.01.011. Epub 2006 Mar 3. Cell Signal. 2006. PMID: 16516442 Review.

4

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. McCubrey JA, et al. Among authors: evangelisti c. Biochim Biophys Acta. 2007 Aug;1773(8):1263-84. doi: 10.1016/j.bbamcr.2006.10.001. Epub 2006 Oct 7. Biochim Biophys Acta. 2007. PMID: 17126425 Free PMC article. Review.

5

The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion.

Tazzari PL, Tabellini G, Bortul R, Papa V, Evangelisti C, Grafone T, Martinelli G, McCubrey JA, Martelli AM. Tazzari PL, et al. Among authors: evangelisti c. Leukemia. 2007 May;21(5):886-96. doi: 10.1038/sj.leu.2404643. Epub 2007 Mar 15. Leukemia. 2007. PMID: 17361225

6

Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

McCubrey JA, Steelman LS, Franklin RA, Abrams SL, Chappell WH, Wong EW, Lehmann BD, Terrian DM, Basecke J, Stivala F, Libra M, Evangelisti C, Martelli AM. McCubrey JA, et al. Among authors: evangelisti c. Adv Enzyme Regul. 2007;47:64-103. doi: 10.1016/j.advenzreg.2006.12.013. Epub 2007 Mar 26. Adv Enzyme Regul. 2007. PMID: 17382374 Free PMC article. No abstract available.

7

Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts.

Evangelisti C, Tazzari PL, Riccio M, Fiume R, Hozumi Y, Falà F, Goto K, Manzoli L, Cocco L, Martelli AM. Evangelisti C, et al. FASEB J. 2007 Oct;21(12):3297-307. doi: 10.1096/fj.07-8336com. Epub 2007 May 8. FASEB J. 2007. PMID: 17488950

8

Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.

Martelli AM, Tazzari PL, Evangelisti C, Chiarini F, Blalock WL, Billi AM, Manzoli L, McCubrey JA, Cocco L. Martelli AM, et al. Among authors: evangelisti c. Curr Med Chem. 2007;14(19):2009-23. doi: 10.2174/092986707781368423. Curr Med Chem. 2007. PMID: 17691943 Review.

9

Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

McCubrey JA, Sokolosky ML, Lehmann BD, Taylor JR, Navolanic PM, Chappell WH, Abrams SL, Stadelman KM, Wong EW, Misaghian N, Horn S, Bäsecke J, Libra M, Stivala F, Ligresti G, Tafuri A, Milella M, Zarzycki M, Dzugaj A, Chiarini F, Evangelisti C, Martelli AM, Terrian DM, Franklin RA, Steelman LS. McCubrey JA, et al. Among authors: evangelisti c. Adv Enzyme Regul. 2008;48:113-35. doi: 10.1016/j.advenzreg.2008.02.006. Epub 2008 Feb 21. Adv Enzyme Regul. 2008. PMID: 18423407 Free PMC article.

10

Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.

McCubrey JA, Abrams SL, Ligresti G, Misaghian N, Wong EW, Steelman LS, Bäsecke J, Troppmair J, Libra M, Nicoletti F, Molton S, McMahon M, Evangelisti C, Martelli AM. McCubrey JA, et al. Among authors: evangelisti c. Leukemia. 2008 Nov;22(11):2080-90. doi: 10.1038/leu.2008.207. Epub 2008 Aug 7. Leukemia. 2008. PMID: 18685611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page